FERMENTA BIOTECH
|
The Current P/E Ratio of FERMENTA BIOTECH is 13.37.
| Share Price | ₹319.6 | Jun 04,2026 |
| Market Cap | ₹939.5 Cr | |
| Earnings-TTM | ₹70.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 13.37x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of FERMENTA BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹939.5 Cr] as on Jun 04,2026
(/) Earnings [ ₹70.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.37x ]
Thus, for FERMENTA BIOTECH , the investors are currently willing to pay 13.37 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FERMENTA BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of FERMENTA BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of FERMENTA BIOTECH
PE Ratio Performance Analysis for FERMENTA BIOTECH
- FERMENTA BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.93x.
- FERMENTA BIOTECH 's operated at median p/e ratio of 10.38x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FERMENTA BIOTECH 's p/e ratio peaked in Mar2022 at 38.41x.
- FERMENTA BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does FERMENTA BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| FERMENTA BIOTECH | 70.26 | 13.37 | 939.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 36.92 | 426,926.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 68.17 | 175,062.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 68.67 | 146,806.0 |
| CIPLA LTD | 3,869.79 | 29.18 | 112,910.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.52 | 105,755.0 |
| MANKIND PHARMA LTD | 1,926.41 | 50.46 | 97,215.3 |
| LUPIN LTD | 5,355.47 | 19.20 | 102,814.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.73 | 109,222.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 24.05 | 84,212.3 |
| LAURUS LABS LTD | 889.85 | 86.59 | 77,048.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FERMENTA BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 13.37x |
| Max industry PE | 86.59x |
| Median industry PE | 29.18x |
| Average industry PE | 40.35x |
You may also like the below Video Courses